M. Janot
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
-
- Renal cell carcinoma treatment
- Gallbladder and Bile Duct Disorders
- Gastric Cancer Management and Outcomes
Papers in
- Co-authors
- Waldemar Uhl (17 shared papers)Ansgar M. Chromik (12 shared papers)Orlin Belyaev (9 shared papers)Alessandro Zerbi (3 shared papers)Matthias H. Seelig (4 shared papers)Giuseppe Malleo (3 shared papers)Maximilian Bockhorn (3 shared papers)Marco Montorsi (3 shared papers)
In The Last Decade
M. Janot
18 papers receiving 350 citations
Peers
Comparison fields: 5 of 32
- Oncology 327
- Pulmonary and Respiratory Medicine 176
- Surgery 193
- Cancer Research 56
- Gastroenterology 17
Countries citing papers authored by M. Janot
This map shows the geographic impact of M. Janot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Janot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Janot more than expected).
Fields of papers citing papers by M. Janot
This network shows the impact of papers produced by M. Janot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Janot. The network helps show where M. Janot may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Janot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 113 | |
| 2 | 2010 | 51 | |
| 3 | 2014 | 49 | |
| 4 | 2012 | 28 | |
| 5 | 2012 | 20 | |
| 6 | 2009 | 14 | |
| 7 | 2016 | 14 | |
| 8 | 2011 | 14 | |
| 9 | 2012 | 13 | |
| 10 | 2013 | 12 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 6 | |
| 13 | 2008 | 6 | |
| 14 | 2018 | 4 | |
| 15 | 2010 | 3 | |
| 16 | 2016 | 3 | |
| 17 | Prognosis and Long-Term Survival after Operation in Patients with Pancreatic and Peripancreatic Neuroendocrine Tumors of a Single Center | 2016 | 2 |
| 18 | 2010 | 2 | |
| 19 | Pankreaslinksresektion: Wann radikal, wann milzerhaltend? | 2008 | 0 |
About M. Janot
M. Janot is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Cancer Research, having authored 19 papers that have together received 360 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Pancreatitis Pathology and Treatment (9 papers), Neuroendocrine Tumor Research Advances (5 papers), Esophageal and GI Pathology (3 papers), Renal cell carcinoma treatment (3 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers) and Gastrointestinal disorders and treatments (2 papers). The work is most often cited by research in Oncology (327 citations), Pulmonary and Respiratory Medicine (176 citations), Surgery (193 citations), Cancer Research (56 citations) and Gastroenterology (17 citations). M. Janot has collaborated with scholars based in Germany, Italy and France. Frequent co-authors include Waldemar Uhl, Ansgar M. Chromik, Orlin Belyaev, Alessandro Zerbi, Matthias H. Seelig, Giuseppe Malleo, Maximilian Bockhorn, Marco Montorsi, Torsten Herzog and Jakob R. Izbicki. Their work appears in journals such as Journal of Gastrointestinal Surgery, Surgery, The American Journal of Surgery, Digestive Surgery and Langenbeck s Archives of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.